Jeil Pharma Holdings Inc

Informe acción KOSE:A002620

Capitalización de mercado: ₩135.6b

Salud financiera de hoja de balance de Jeil Pharma Holdings

Salud financiera controles de criterios 5/6

Jeil Pharma Holdings has a total shareholder equity of ₩436.3B and total debt of ₩149.4B, which brings its debt-to-equity ratio to 34.2%. Its total assets and total liabilities are ₩881.2B and ₩444.9B respectively.

Información clave

34.2%

Ratio deuda-patrimonio

₩149.39b

Deuda

Ratio de cobertura de interesesn/a
Efectivo₩48.04b
Patrimonio₩436.29b
Total pasivo₩444.87b
Activos totales₩881.15b

Actualizaciones recientes sobre salud financiera

Recent updates

Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

Mar 25
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

Feb 27
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jan 23
What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Dec 28
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Nov 23
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Análisis de la situación financiera

Pasivos a corto plazo: A002620's short term assets (₩387.7B) exceed its short term liabilities (₩376.7B).

Pasivo a largo plazo: A002620's short term assets (₩387.7B) exceed its long term liabilities (₩68.1B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: A002620's net debt to equity ratio (23.2%) is considered satisfactory.

Reducción de la deuda: A002620's debt to equity ratio has increased from 14.3% to 34.2% over the past 5 years.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: A002620 has sufficient cash runway for more than 3 years based on its current free cash flow.

Pronóstico de cash runway: A002620 has sufficient cash runway for 2.6 years if free cash flow continues to grow at historical rates of 9% each year.


Descubre empresas con salud financiera